Skip to content

Effects of Liquid Zinc Supplementation and Dispersible Zinc Tablets on Plasma Zinc Concentration

The Effect of Zinc Supplementation, Provided as Either a Liquid Zinc Solution or Dispersible Tablets, on Plasma Zinc Concentration Among Young Burkinabe Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00944853
Enrollment
462
Registered
2009-07-23
Start date
2009-08-31
Completion date
2010-02-28
Last updated
2017-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zinc Deficiency

Keywords

zinc supplement, prevention, zinc deficiency, plasma zinc concentration

Brief summary

The study aims to compare the effects of two different formulations of zinc supplements on plasma zinc concentrations among young Burkinabe children.

Detailed description

1\) To investigate the effects of short-term zinc supplementation, provided either as a dispersible tablet containing zinc sulfate (ZinCfant, Nutriset Ltd; Malaunay, France) or as a liquid ZnSO4 solution, on changes in serum zinc concentration, compared with a placebo in young Burkinabe children; and 2) to assess the relationship between change in serum zinc concentration and the presence of altered intestinal permeability within each treatment group.

Interventions

DIETARY_SUPPLEMENTLiquid zinc syrup

Liquid zinc syrup containing 5 mg zinc as zinc sulfate

DIETARY_SUPPLEMENTZinc tablet

Dispersible zinc tablet containing 5 mg zinc

DIETARY_SUPPLEMENTLiquid placebo supplement

Liquid placebo supplement containing 0 mg zinc

Sponsors

Université Polytechnique de Bobo-Dioulasso
CollaboratorOTHER
Helen Keller International
CollaboratorOTHER
Nutriset
CollaboratorINDUSTRY
University of California, Davis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Months to 23 Months
Healthy volunteers
Yes

Inclusion criteria

* currently breast feeding * informed consent of a parent or guardian.

Exclusion criteria

* symptomatic acute or chronic febrile infections * diarrhea within the past week * consuming vitamin or mineral supplements or zinc-fortified infant formulas

Design outcomes

Primary

MeasureTime frame
Plasma zinc concentration3 weeks

Countries

Burkina Faso

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026